Clinical Trials Browser

Terminated × INDUSTRY × oregovomab × Clear all

NCT03162562 2020-12-22

The Safety and Antitumor Activity of the Combination of Oregovomab and Hiltonol in Recurrent Advanced Ovarian Cancer

Phase 1 Terminated

Ovarian Neoplasms

NCT00034138 2007-12-18

A Comparative Pharmacokinetics and Safety Study of OvaRex MAb-B43.13 in Patients With Ovarian Epithelial Carcinoma

Phase 1/2 Terminated

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT00050375 2007-12-18

Clinical Trial for Ovarian Cancer (OvaRex®)

Phase 3 Terminated

Ovarian Neoplasms